Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 985176, 8 pages
http://dx.doi.org/10.1155/2014/985176
Research Article

Anti-Inflammatory Effects of 81 Chinese Herb Extracts and Their Correlation with the Characteristics of Traditional Chinese Medicine

Shanghai University of Traditional Chinese Medicine, Pudong, Shanghai 201203, China

Received 26 November 2013; Accepted 13 January 2014; Published 20 February 2014

Academic Editor: Yemeng Chen

Copyright © 2014 Chang-Liang Chen and Dan-Dan Zhang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Y. Chen and G. Nuñez, “Sterile inflammation: sensing and reacting to damage,” Nature Reviews Immunology, vol. 10, no. 12, pp. 826–837, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Ross, “Atherosclerosis—an inflammatory disease,” The New England Journal of Medicine, vol. 340, no. 2, pp. 115–126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. H. L. Weiner and D. Frenkel, “Immunology and immunotherapy of Alzheimer's disease,” Nature Reviews Immunology, vol. 6, no. 5, pp. 404–416, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Garcia, B. Feve, P. Ferré et al., “Diabetes and inflammation: fundamental aspects and clinical implications,” Diabetes and Metabolism, vol. 36, no. 5, pp. 327–338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. L. M. Coussens and Z. Werb, “Inflammation and cancer,” Nature, vol. 420, no. 6917, pp. 860–867, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Clevers, “At the crossroads of inflammation and cancer,” Cell, vol. 118, no. 6, pp. 671–674, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. C. J. Lowenstein and E. Padalko, “iNOS (NOS2) at a glance,” Journal of Cell Science, vol. 117, no. 14, pp. 2865–2867, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. C. V. Suschek, O. Schnorr, and V. Kolb-Bachofen, “The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all?” Current Molecular Medicine, vol. 4, no. 7, pp. 763–775, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. G. C. Brown, “Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase,” Biochemical Society Transactions, vol. 35, no. 5, pp. 1119–1121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. H. H. Schmidt and U. Walter, “NO at work,” Cell, vol. 78, no. 6, pp. 919–925, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Bian and F. Murad, “Nitric oxide (NO)—biogeneration, regulation, and relevence to human diseases,” Frontiers in Bioscience, vol. 8, pp. d264–d278, 2003. View at Google Scholar · View at Scopus
  13. H. Ohshima and H. Bartsch, “Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis,” Mutation Research, vol. 305, no. 2, pp. 253–264, 1994. View at Publisher · View at Google Scholar · View at Scopus
  14. J. R. Kanwar, R. K. Kanwar, H. Burrow, and S. Baratchi, “Recent advances on the roles of NO in cancer and chronic inflammatory disorders,” Current Medicinal Chemistry, vol. 16, no. 19, pp. 2373–2394, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Heemskerk, R. Masereeuw, F. G. Russel, and P. Pickkers, “Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury,” Nature Reviews Nephrology, vol. 5, no. 11, pp. 629–640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Kostourou, J. E. Cartwright, A. P. Johnstone et al., “The role of tumour-derived iNOS in tumour progression and angiogenesis,” British Journal of Cancer, vol. 104, no. 1, pp. 83–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Hesslinger, A. Strub, R. Boer, W.-R. Ulrich, M. D. Lehner, and C. Braun, “Inhibition of inducible nitric oxide synthase in respiratory diseases,” Biochemical Society Transactions, vol. 37, no. 4, pp. 886–891, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Lechner, P. Lirk, and J. Rieder, “Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin,” Seminars in Cancer Biology, vol. 15, no. 4, pp. 277–289, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Fitzpatrick, M. Mehibel, R. L. Cowen, and I. J. Stratford, “iNOS as a therapeutic target for treatment of human tumors,” Nitric Oxide, vol. 19, no. 2, pp. 217–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. G.-Y. Yang, S. Taboada, and J. Liao, “Induced nitric oxide synthase as a major player in the oncogenic transformation of inflamed tissue,” Methods in Molecular Biology, vol. 512, pp. 119–156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. M. Ulrich, J. Bigler, and J. D. Potter, “Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics,” Nature Reviews Cancer, vol. 6, no. 2, pp. 130–140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. E. J. Jacobs, “Will an aspirin a day help keep fatal cancer away?” The Lancet, vol. 377, no. 9759, pp. 3–4, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Basha, C. H. Baker, U. T. Sankpal et al., “Therapeutic applications of NSAIDS in cancer: special emphasis on tolfenamic acid,” Frontiers in Bioscience, vol. 3, pp. 797–805, 2011. View at Google Scholar · View at Scopus
  24. B. B. Aggarwal, R. V. Vijayalekshmi, and B. Sung, “Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe,” Clinical Cancer Research, vol. 15, no. 2, pp. 425–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Murakami and H. Ohigashi, “Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals,” International Journal of Cancer, vol. 121, no. 11, pp. 2357–2363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Bengmark, “Curcumin, an atoxic antioxidant and natural NF-κB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases,” Journal of Parenteral and Enteral Nutrition, vol. 30, no. 1, pp. 45–51, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. V. B. Patel, S. Misra, B. B. Patel, and A. P. Majumdar, “Colorectal cancer: chemopreventive role of curcumin and resveratrol,” Nutrition and Cancer, vol. 62, no. 7, pp. 958–967, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. C. H. Hong, S. K. Hur, O.-J. Oh, S. S. Kim, K. A. Nam, and S. K. Lee, “Evaluation of natural products on inhibition of inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) in cultured mouse macrophage cells,” Journal of Ethnopharmacology, vol. 83, no. 1-2, pp. 153–159, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Murakami, “Chemoprevention with phytochemicals targeting inducible nitric oxide synthase,” Forum of Nutrition, vol. 61, pp. 193–203, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Cerella, C. Sobolewski, M. Dicato, and M. Diederich, “Targeting COX-2 expression by natural compounds: a promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy,” Biochemical Pharmacology, vol. 80, no. 12, pp. 1801–1815, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Liao, L. K. Banbury, and D. N. Leach, “Antioxidant activity of 45 Chinese herbs and the relationship with their TCM characteristics,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 4, pp. 429–434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. L. C. Green, D. A. Wagner, J. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum, “Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids,” Analytical Biochemistry, vol. 126, no. 1, pp. 131–138, 1982. View at Google Scholar
  33. B. Ayissi Owona, N. F. Njayou, S. Laufer, P. F. Moundipa, and H. J. Schluesener, “A fraction of stem bark extract of Entada africana suppresses lipopolysaccharide-induced inflammation in RAW 264.7 cells,” Journal of Ethnopharmacology, vol. 149, no. 1, pp. 162–168, 2013. View at Publisher · View at Google Scholar
  34. Y. Wu, S. Antony, J. L. Meitzler, and J. H. Doroshow, “Molecular mechanisms underlying chronic inflammation-associated cancers,” Cancer Letters, 2013. View at Publisher · View at Google Scholar
  35. A. G. Sikora, A. Gelbard, M. A. Davies et al., “Targeted inhibition of inducible nitric oxide synthase inhibits growth of human melanoma in vivo and synergizes with chemotherapy,” Clinical Cancer Research, vol. 16, no. 6, pp. 1834–1844, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Engels, S. K. Knauer, S. Loibl et al., “NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas,” Cancer Research, vol. 68, no. 13, pp. 5159–5166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. K. S. Kim, X. Cui, D. S. Lee et al., “Anti-inflammatory effect of neoechinulin A from the marine fungus Eurotium sp. SF-5989 through the suppression of NF-κB and p38 MAPK pathways in lipopolysaccharide-stimulated RAW264.7 macrophages,” Molecules, vol. 18, no. 11, pp. 13245–13259, 2013. View at Publisher · View at Google Scholar
  38. H. J. Lee, Y. J. Jeong, T. S. Lee et al., “Moringa fruit inhibits LPS-induced NO/iNOS expression through suppressing the NF-κ B activation in RAW264.7 cells,” The American Journal of Chinese Medicine, vol. 41, no. 5, pp. 1109–11023, 2013. View at Publisher · View at Google Scholar
  39. S. Li, G. Chou, Y. Hseu, H. Yang, H. Kwan, and Z. Yu, “Isolation of anticancer constituents from flos genkwa (Daphne genkwa Sieb.et Zucc.) through bioassay-guided procedures,” Chemistry Central Journal, vol. 7, article 159, 2013. View at Publisher · View at Google Scholar
  40. Z. G. Zhu, H. Jin, P. J. Yu, Y. X. Tian, J. J. Zhang, and S. G. Wu, “Mollugin inhibits the inflammatory response in lipopolysaccharide-stimulated RAW264.7 macrophages by blocking the Janus kinase-signal transducers and activators of transcription signaling pathway,” Biological & Pharmaceutical Bulletin, vol. 36, no. 3, pp. 399–406, 2013. View at Publisher · View at Google Scholar